Estimate your clinical trial budget
Use this calculator to get a quick, directional estimate for total trial spend. Adjust assumptions to model different scenarios.
Educational estimator only. Real budgets depend on protocol complexity, geography, enrollment velocity, monitoring strategy, and vendor contracts.
Why a clinical trial cost calculator matters
Trial budgeting is where science, operations, and finance collide. If your cost assumptions are too low, you can burn runway before recruitment ends. If assumptions are too high, promising programs may be rejected too early. A practical cost model helps teams make faster go/no-go decisions, compare protocol options, and prepare better investor or internal funding conversations.
This calculator is designed for early planning. It gives you a structured way to think about major expense buckets and identify which drivers are truly moving your budget.
Key cost drivers in clinical trials
1) Participant-related costs
These include screening, visits, labs, imaging, stipends, and adverse event management. The direct cost per participant often expands as inclusion criteria tighten or visit schedules become more intensive.
2) Site count and site performance
More sites can improve recruitment speed, but each site introduces startup, training, contracts, and oversight overhead. High-performing sites can reduce timeline risk, while low-performing sites increase both timeline and cost risk.
3) Trial duration
Every month adds recurring expenses: clinical operations, data handling, monitoring, and vendor fees. Delays are expensive, so timeline realism is as important as cost realism.
4) Centralized operations and vendors
CRO management, eTMF, EDC, pharmacovigilance, biostatistics, and medical writing can become large fixed or semi-fixed budget components. Vendor scope clarity is essential to avoid change-order surprises.
5) Contingency planning
Most trials face protocol amendments, slower enrollment, or data cleaning surprises. A contingency reserve helps protect continuity and reduces the need for emergency financing.
How to use this estimator well
- Model three scenarios: base case, optimistic case, and stress case.
- Separate fixed vs. variable costs: this clarifies what scales with enrollment and what does not.
- Recalculate monthly: update assumptions as enrollment and site metrics change.
- Track cost per enrolled participant: this metric is easy to benchmark across periods.
- Use contingency intentionally: not as a guess, but as a risk-adjusted reserve.
Example interpretation of results
Suppose your model shows a total budget of $8.5M with a cost per participant near $47k. You can then ask:
- Can protocol simplification reduce visit burden and direct participant cost?
- Could fewer but stronger sites maintain enrollment pace while reducing overhead?
- Would centralized monitoring lower recurring monthly site management spend?
- Is your contingency percentage aligned with operational uncertainty?
The goal is not perfection. The goal is decision quality: understanding where dollars go and which levers change outcomes.
Budget optimization strategies
Improve enrollment forecasting
Unrealistic enrollment assumptions are one of the biggest hidden budget risks. Use historical site performance, not aspirational targets.
Design for operational feasibility
Complex protocols can create expensive bottlenecks. Practical eligibility criteria and streamlined visit schedules can preserve data quality while reducing site strain.
Build a vendor governance rhythm
Monthly financial and scope reviews with key vendors help detect scope drift early. That is often where avoidable costs begin.
Invest in data quality early
Underfunding data management creates downstream cleaning and analysis delays. Early investment usually lowers total study cost and protects timelines.
Final thoughts
A clinical trial budget is a living model, not a one-time spreadsheet. As recruitment, retention, and protocol realities emerge, your budget should evolve in lockstep. Use this calculator as a decision-support tool, then refine assumptions with your clinical operations, biostatistics, medical, and finance teams.